Internal Medicine, Pulmonary Disease · Bronx, NY
NPI
1235267576
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1650 Grand Concourse
Bronx, NY, 10457
Phone (718) 901-8918
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
367 services
Medicare patients, 2024
191
Average age 74
Drug cost, 2024
$684K
3,827 prescriptions
Company payments, 2025
$200
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Misbahuddin Khaja was code 99291 (critical care e&m), 138 times for 84 patients. In total Misbahuddin Khaja billed 367 services in 15 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 138 | 84 | $178.92 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 70 | 38 | $69.76 | $4,883 |
| 99238 Hospital Discharge Management | Facility | 48 | 48 | $70.88 | $3,402 |
| 99222 Hospital E&M - Initial | Facility | 33 | 31 | $115.99 | $3,828 |
| 99233 Hospital E&M - Subsequent | Facility | 29 | 11 | $104.93 | $3,043 |
By year: 2022 $72K for 634 services; 2023 $73K for 639 services; 2024 $44K for 367 services.
Medicare prescription drug claims, 2024
In 2024, the drug Misbahuddin Khaja prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,042 prescriptions and refills. In total Misbahuddin Khaja wrote 3,827 Medicare prescriptions that cost $684K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,042 | 1,252 | 217 | $37K |
| Montelukast Sodium Generic | 567 | 785 | 121 | $3,355 |
| Incruse Ellipta Umeclidinium Bromide | 306 | 370 | 75 | $120K |
| Breo Ellipta Fluticasone/Vilanterol | 278 | 317 | 68 | $120K |
| Fluticasone Propionate Generic | 151 | 181 | 40 | $1,006 |
| Prednisone Generic | 143 | 157 | 75 | $253 |
| Symbicort Budesonide/Formoterol Fumarate | 125 | 142 | 58 | $28K |
| Omeprazole Generic | 124 | 145 | 27 | $769 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 91 | 97 | 25 | $16K |
| Ventolin Hfa Albuterol Sulfate | 83 | 106 | 21 | $5,920 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 61 | 63 | 16 | $38K |
| Roflumilast Generic | 59 | 82 | 16 | $7,469 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 43 | 45 | 13 | $28K |
| Atorvastatin Calcium Generic | 41 | 99 | 31 | $392 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 38 | 42 | Under 11 | $4,531 |
Brand drugs: 1,876 claims; generic drugs: 1,917 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Misbahuddin Khaja $200 ($200 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $151.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.